Why a new opioid alternative is out of reach for s... NPR

Why a new opioid alternative is out of reach for some pain patients

NPR July 10, 2025

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.<br /><br />

Comments 0

Log in to post a comment.

No comments yet. Be the first to comment!

Advertise with Us

Reach our audience with your ads